Exploration of genetic variants in PRL and PRLR has identified single-nucleotide polymorphisms (SNPs) that alter transcription factor binding [16], modify prolactin receptor activity [17,18], and may be associated with breast cancer risk [19,20] or circulating prolactin levels [19]. Here, PRL is linked to breast carcinoma.